Financial Overview
Cash at end of 1Q 2001: $68.1 million
Cash burn for 1Q 2001: $14.8 million
- $11.7 million – operating costs
- $3.1 million – inventory payments
PIPE completed in May 2001
- Gross proceeds of $35 million to Amylin
- Increased support for current activities
- AC2993 and AC2993 LAR development programs
- SYMLIN commercialization activities